ERH-14743-65349
3 vaccinations
5 coded responses
27 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 148 / NY
- Registered
- 2021-11-12
- Relationship
- Child or adolescent in my care
- Guardian
- BG3-72318-41985
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-12
Registered in v-safe
-
2021-11-12
Dose 1 — Pfizer-BioNTech
- 2021-11-12
-
2021-11-13
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-14
- 2021-11-17
- 2021-11-21
- 2021-11-26
-
2021-12-03
Dose 2 — Pfizer-BioNTech
-
2021-12-04
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Itching · NoneAdult check-in
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-03-04
-
2022-06-03
Survey response — 6 months, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: One non-COVID coldMedDRA releases: 2024-11 · check-in free text available
-
2022-11-23
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-03
Survey response — day 7, dose 3, dependentMedDRA: Cough — Feeling: FairFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-07
- 2022-12-14
-
2022-12-21
Survey response — day 28, dose 3, dependentMedDRA: Cough, Respiratory tract congestion, Rhinorrhoea, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Upper respiratory infection with cough, congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-31
Survey response — day 35, dose 3, dependentMedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: 12/19/22 had cough, runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-04
- 2023-02-22
-
2023-05-24
Survey response — 6 months, dose 3, dependentMedDRA: Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-12 | Pfizer-BioNTech | No |
| 2 | 2021-12-03 | Pfizer-BioNTech | No |
| 3 | 2022-11-23 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 6 months, dose 2, dependent
Symptoms: One non-COVID cold
Release 12 — day 7, dose 3, dependent
Systemic reaction (other): Cough
Release 12 — day 28, dose 3, dependent
Symptoms: Upper respiratory infection with cough, congestion, runny nose
Release 12 — day 35, dose 3, dependent
Symptoms: 12/19/22 had cough, runny nose, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release